Rexall Sundown Cellasene Sales Reach $35 Mil. In Third Quarter
This article was originally published in The Tan Sheet
Executive Summary
Reflecting retailers' initial pipeline purchases, sales of the Cellasene cellulite-reducing dietary supplement were $35 mil. for the fiscal third quarter (ended May 31), an "all-time record" for the company, Rexall Sundown said during a June 15 teleconference. Initial Cellasene sales exceeded the firm's previous record of $32 mil. for Osteo Bi-Flex in the fourth quarter of fiscal 1998.
You may also be interested in...
Rexall Sundown Cellasene Claims Cited In FTC Complaint
Claims made by Rexall Sundown in support of its Cellasene cellulite-reducing dietary supplement are "false and misleading," the Federal Trade Commission charges in a July 19 complaint.
Rexall Sundown Cellasene Claims Cited In FTC Complaint
Claims made by Rexall Sundown in support of its Cellasene cellulite-reducing dietary supplement are "false and misleading," the Federal Trade Commission charges in a July 19 complaint.
Rexall Sundown Cellasene Claims Cited In FTC Complaint
Claims made by Rexall Sundown in support of its Cellasene cellulite-reducing dietary supplement are "false and misleading," the Federal Trade Commission charges in a July 19 complaint.